Skip to main content
SpringerLink
Log in

Effects of acetylcholinesterase inhibitors on nutritional status in elderly patients with dementia: A 6-month follow-up study

  • Published:
The journal of nutrition, health & aging

Abstract

Objectives

Nutritional status is one of the factors that affects disease progression, morbidity and mortality in elderly patients with dementia. The present study aimed to evaluate the effect of acetylcholinesterase inhibitor (AchEI) therapy on nutritional status and food intake in the elderly.

Design, setting and participants

Newly diagnosed patients with dementia, who underwent comprehensive geriatric assessment (CGA) and were followed at regular intervals, were retrospectively evaluated. A total of 116 patients, who began to receive AchEI therapy and completed 6-month follow-up period under this treatment, were enrolled in the study.

Measurements

Socio-demographic characteristics and data on comorbidity, polypharmacy, cognitive function, depression, activities of daily living and nutritional status (weight, Body Mass Index (BMI), Mini Nutritional Assessment (MNA)-Short Form) were recorded.

Results

The mean age of the patients was 78.0±8.9 years. There was no significant difference between baseline and 6-month BMI, weight and MNA scores of dementia patients who received AchEI therapy (p>0.05). With regard to the relation between changes in BMI, weight and MNA on the 6th month versus baseline, and donepezil, rivastigmine and galantamine therapies, no difference was determined (p>0.05). However, no worsening in food intake was observed (kappa: 0.377). When the effects of each AchEI on food intake were compared, food intake in rivastigmine treated patients was not decreased as much as it was in galantamine or donepezil treated patients (p<0.05).

Conclusion

AchEI therapy has no unfavorable effect on nutritional status or weight in elderly patients with different types of dementia, but it seems that food intake is better in those treated by rivastigmine patch.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Table 1
Table 2
Table 3

Similar content being viewed by others

References

  1. Orsitto G. Different components of nutritional status in older inpatients with cognitive impairment. J Nutr Health Aging. 2012;16(5):468–71.

    Article  CAS  PubMed  Google Scholar 

  2. Volicer L, Seltzer B, Rheaume Y, Karner J, Glennon M, Riley ME, Crino P. Eating difficulties in patients with probable dementia of the Alzheimer type. J Geriatr Psychiatry Neurol. 1998;2(4):188–95

    Article  Google Scholar 

  3. Sergi G, De Rui M, Coin A, Inelmen EM, Manzato E. Weight loss and Alzheimer’s disease: temporal and aetiologic connections. Proc Nutr Soc. 2013;72(1):160–5.

    Article  PubMed  Google Scholar 

  4. Uwano C, Suzuki M, Aikawa T et al. Rivastigmine dermal patch solves eating problems in an individual with advanced Alzheimer’s disease. J Am Geriatr Soc. 2012;60(10):1979–80.

    Article  PubMed  Google Scholar 

  5. Schofield PW, Finnie S, Yong YM. The role of olfactory challenge tests in incipient dementia and clinical trial design. Curr Neurol Neurosci Rep. 2014;14(9):479

    Article  PubMed  Google Scholar 

  6. Claggett MS. Nutritional factors relevant to Alzheimer’s disease. J Am Diet Assoc 1989;89:392e6

    Google Scholar 

  7. Khater MS, Abouelezz NF. Nutritional status in older adults with mild cognitive impairment living in elderly homes in Cairo, Egypt. J Nutr Health Aging. 2011;15(2):104–8

    Article  PubMed  Google Scholar 

  8. Roqué M, Salvà A, Vellas B. Malnutrition in community-dwelling adults with dementia (NutriAlz Trial). J Nutr Health Aging. 2013;17(4):295–9.

    Article  PubMed  Google Scholar 

  9. Vellas B, Lauque S, Gillette-Guyonnet S et al. Impact of nutritional status on the evolution of Alzheimer’s disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging. 2005;9(2):75–80.

    CAS  PubMed  Google Scholar 

  10. Guerin O, Soto ME, Brocker P, Robert PH, Benoit M, Vellas B; REAL. FR Group. Nutritional status assessment during Alzheimer’s disease: results after one year (the REAL French Study Group). J Nutr Health Aging. 2005;9(2):81–4.

    CAS  PubMed  Google Scholar 

  11. Lam B, Hollingdrake E, Kennedy JL, Black SE, Masellis M. Cholinesterase inhibitors in Alzheimer’s disease and Lewy body spectrum disorders: the emerging pharmacogenetic story. Hum Genomics. 2009;4(2):91–106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Baskys A, Cheng JX. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Exp Gerontol. 2012;47(11):887–91

    Article  CAS  PubMed  Google Scholar 

  13. Boeve BF, Josephs KA, Drubach DA. Current and future management of the corticobasal syndrome and corticobasal degeneration. Handb Clin Neurol. 2008;89:533–48.

    Article  PubMed  Google Scholar 

  14. Droogsma E, van Asselt DZ, van Steijn JH, Schuur T, Huinink EJ. Effect of longterm treatment with galantamine on weight of patients with Alzheimer’s dementia. J Nutr Health Aging. 2013;17(5):461–5.

    Article  CAS  PubMed  Google Scholar 

  15. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders 4th ed., text rev.; DSM-IV-TR, 2000

  16. Soysal P, Isik AT, Buyukaydin B, Kazancioglu RA. Comparison of end-stage renal disease and Alzheimer’s disease in the elderly through a comprehensive geriatric assessment. Int Urol Nephrol. 2014;46(8):1627–32.

    Article  PubMed  Google Scholar 

  17. Dina Zekrya, Bernardo Hermont Loures Valleb, Claudia Lardia et al. Geriatrics index of comorbidity was the most accurate predictor of death in geriatric hospital among six comorbidity scores. Journal of Clinical Epidemiology. 2010;63:1036–1044.

    Article  Google Scholar 

  18. Babacan-Yildiz G, Isik AT, Ur E et al. COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients. Int Psychogeriatr. 2013;25:403–12.

    Article  PubMed  Google Scholar 

  19. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198

    Article  CAS  PubMed  Google Scholar 

  20. Alexopoulos GS, Abrams RC, Young RC, et al. «Cornell Scale for Depression in Dementia». Biological Psychiatry. 1988;23(3): 271–284.

    Article  CAS  PubMed  Google Scholar 

  21. Mahoney F. Barthel D. «Functional evaluation: the Barthel Index». Md Med J. 1965;14:61–65

    CAS  Google Scholar 

  22. Lawton, M.P., Brody, E.M. Assessment of older people: Self-maintaining and instrumental activities of daily living. The Gerontologist. 1969;9(3):179–186.

    Article  CAS  PubMed  Google Scholar 

  23. Zarit S.H., Reever K.E., Bach-Peterson J. Relatives of the impaired elderly: correlated of feelings of burden. Gerontologist. 1980;20, 649–655.

    Article  CAS  PubMed  Google Scholar 

  24. Vellas B, Guigoz Y, Garry PJ et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition. 1999;15(2):116–22.

    Article  CAS  PubMed  Google Scholar 

  25. Soysal P, Isik AT, Ugur A, Kazancioglu R, Ergun F, Babacan Yildiz G. Vitamin B12 and folic acid levels are not related to length of stay in elderly inpatients. Nutrition. 2013;29(5):757–9.

    Article  CAS  PubMed  Google Scholar 

  26. Saka B, Kaya O, Ozturk GB, Erten N, Karan MA. Malnutrition in the elderly and its relationship with other geriatric syndromes. Clin Nutr. 2010;29(6):745–8.

    Article  PubMed  Google Scholar 

  27. Herrmann N, Lanctôt KL, Hogan DB. Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia Alzheimers Res Ther. 2013;8:5.

    Google Scholar 

  28. Stewart JT, Gorelik AR. Involuntary weight loss associated with cholinesterase inhibitors in dementia. J Am Geriatr Soc. 2006;54(6):1013–4.

    Article  PubMed  Google Scholar 

  29. Raskind MA, Peskind ER, Wessel T, Yuan W. Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology. 2000;27;54(12):2261–8.

    Article  Google Scholar 

  30. Gillette-Guyonnet S, Cortes F, Cantet C, Vellas B; REAL.FR Group. Long-term cholinergic treatment is not associated with greater risk of weight loss during Alzheimer’s disease: data from the French REAL.FR cohort. J Nutr Health Aging. 2005;9(2):69–73.

    CAS  PubMed  Google Scholar 

  31. Kaiser MJ, Bauer JM, Ramsch C et al. MNA-International Group Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13(9):782–8

    Article  CAS  PubMed  Google Scholar 

  32. Cortes F, Portet F, Touchon J, Vellas B. Six and 18-month changes in mild to moderate Alzheimer’s patients treated with acetylcholinesterase inhibitors: what can we learn for clinical outcomes of therapeutic trials? J Nutr Health Aging. 2007;11(4):330–7

    CAS  PubMed  Google Scholar 

  33. Cortes F, Gillette-Guyonnet S, Nourhashemi F. Recent data on the natural history of Alzheimer’s disease: results from the REAL.FR Study. J Nutr Health Aging. 2005;9(2):86–93.

    CAS  PubMed  Google Scholar 

  34. de Toledo-Morrell L, Dickerson B, Sullivan MP et al. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer’s disease. Hippocampus 2000;10, 136–142. 33

    Article  PubMed  Google Scholar 

  35. Ober BA, Jagust WJ, Koss E et al. Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer’s disease. J Clin Exp Neuropsychol 1991;13, 752–772

    Article  CAS  PubMed  Google Scholar 

  36. Lyketsos CG, Lopez O, Jones B et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288, 1475–1483.

    Article  PubMed  Google Scholar 

  37. Dando R, Roper SD. Acetylcholine is released from taste cells, enhancing taste signalling. J Physiol. 2012;1;590(Pt 13):3009–17.

    Article  Google Scholar 

  38. Jia YX, Li JQ, Matsui T et al. Neurochemical regulation of swallowing reflex in guinea pigs. Geriatr Gerontol Int. 2001;1:56–61.

    Article  Google Scholar 

  39. Lee JH, Sevigny J. Effects of body weight on tolerability of rivastigmine transdermal patch: a post-hoc analysis of a double-blind trial in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2011;25(1):58–62.

    Article  CAS  PubMed  Google Scholar 

  40. Nakamura Y, Imai Y, Shigeta M et al. A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2011;1(1):163–79..

    Article  PubMed  PubMed Central  Google Scholar 

  41. Wilson MM, Thomas DR, Rubenstein LZ et al. Appetite assessment: simple appetite questionnaire predicts weight loss in community-dwelling adults and nursing home residents. Am J Clin Nutr. 2005;82(5):1074–81

    CAS  PubMed  Google Scholar 

  42. Tully MW, Lambros Matrakas K, Musallam K. The eating behavior scale: a simple method of assessing functional ability in patients with Alzheimer’s disease. J Nutr Health Aging. 1998;2(2):119–21

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Aging Brain and Dementia, Department of Geriatric Medicine, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey

    P. Soysal & Ahmet Turan Isik

Authors
  1. P. Soysal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ahmet Turan Isik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmet Turan Isik.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Soysal, P., Isik, A.T. Effects of acetylcholinesterase inhibitors on nutritional status in elderly patients with dementia: A 6-month follow-up study. J Nutr Health Aging 20, 398–403 (2016). https://doi.org/10.1007/s12603-015-0603-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-015-0603-z

Keywords

Search

Navigation